Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats
- 1 August 1997
- journal article
- Published by Elsevier in Neuroscience
- Vol. 81 (1), 141-149
- https://doi.org/10.1016/s0306-4522(97)00192-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Riluzole Reduces Incidence of Abnormal Movements but Not Striatal Cell Death in a Primate Model of Progressive Striatal DegenerationExperimental Neurology, 1997
- Riluzole AnesthesiaAnesthesiology, 1996
- Aging, energy, and oxidative stress in neurodegenerative diseasesAnnals of Neurology, 1995
- Characterization of the Excitotoxic Potential of the Reversible Succinate Dehydrogenase Inhibitor MalonateJournal of Neurochemistry, 1995
- NMDA Receptor Involvement in Toxicity to Dopamine Neurons In Vitro Caused by the Succinate Dehydrogenase Inhibitor 3‐Nitropropionic AcidJournal of Neurochemistry, 1995
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathologyCellular and Molecular Life Sciences, 1993
- Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivoNeuroscience Letters, 1992
- Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on d[3H]aspartate release from cultured cerebellar granule cellsNeuroscience Letters, 1992
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986